MYC and neoplasm: In addition, identifying the unique vulnerabilities that arise in a MYC-driven tumour can reveal targetable synthetic lethal interactions (Horiuchi et al., 2016; Hsu et al., 2015; Sato et al., 2015; Toyoshima et al., 2012; Zhou et al., 2014).